Teleconsultation in Ambulatory Care in France (TELET)

Observational Study of the Use of the Service Giving Access to Teleconsultation in France by Telemedicine Companies

Teleconsultation is a telemedicine medical act carried out remotely via information and communication technologies. This medical procedure has been legal in France since 2010 and reimbursed by the National Health Insurance under certain conditions since 2018. In 2020, following the COVID-19 epidemic, the lockdowns and the extension of the scope of financial coverage, 17 million teleconsultations have been reimbursed.

To date, few scientific studies have been published in France to precisely describe the use of the service giving access to outpatient teleconsultation, in particular since the major increase in activity linked to the COVID-19 epidemic.

The objective is to describe the use of the service giving access to outpatient teleconsultation carried out in France by teleconsultation companies and compare the use of the teleconsultation service according to the medical density of the territory.

Study Overview

• Status: Completed
• Conditions: Telemedicine; Telehealth; Teleconsultation

• Study Type: Observational
• Enrollment (Actual): 84000

Contacts and Locations

Study Locations

• France
  • Paris, France
    • Les Entreprises de Télémédecine

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: ADULT; OLDER_ADULT; CHILD
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

• Sampling Method: Probability Sample

Study Population

Patients registered with a teleconsultation company member of the LET participating to the study with at least one teleconsultation during the study period.

Description

Inclusion Criteria:

• Patient who used the teleconsultation access service with one of the telemedicine companies member of the LET participating in the study
• Patient residing in France according to the written information (address and or postal code) given at registration to the telemedicine company
• Teleconsultation service used between August 1, 2021 and November 30, 2021
• Teleconsultation service used in the context of outpatient care (hospitals excluded)
• Teleconsultation service used for a teleconsultation with a doctor registered with the Medical Doctors Council in France

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Time Frame
Rate of patients without a treating doctor	Through the study completion at the time of the teleconsultation, average 1 day

Collaborators and Investigators

• Sponsor: Les Entreprises de Télémédecine
• Investigators: Principal Investigator: Julie Salomon, MD, Qare

Study record dates

Study Major Dates

• Study Start (ACTUAL): February 1, 2022
• Primary Completion (ACTUAL): March 21, 2022
• Study Completion (ACTUAL): March 21, 2022

Study Registration Dates

• First Submitted: March 25, 2022
• First Submitted That Met QC Criteria: April 4, 2022
• First Posted (ACTUAL): April 5, 2022

Study Record Updates

• Last Update Posted (ACTUAL): April 5, 2022
• Last Update Submitted That Met QC Criteria: April 4, 2022
• Last Verified: April 1, 2022

More Information

Terms related to this study

• Other Study ID Numbers: 001 (Buy Pharma Ecza Deposu San. Tic. Ltd.)

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No